Oxidative stress-driven mechanisms of nordihydroguaiaretic acid-induced apoptosis in FL5.12 cells

被引:26
作者
Deshpande, Vaidehee S. [1 ]
Kehrer, James P. [1 ]
机构
[1] Univ Texas, Coll Pharm, Dept Pharmacol & Toxicol, Austin, TX 78712 USA
关键词
NDGA; apoptosis; oxidative stress; MAPK; mitochondria;
D O I
10.1016/j.taap.2005.12.011
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Nordihydroguaiaretic acid (NDGA), a general lipoxygenase (LOX) enzyme inhibitor, induces apoptosis independently of its activity as a LOX inhibitor in murine pro-B lymphocytes (FL.12 cells) by a mechanism that is still not fully understood. Glutathione depletion, oxidative processes and mitochondrial depolarization appear to contribute to the apoptosis induced by NDGA. The current data demonstrate that NDGA (20 mu M)-induced apoptosis in FL5.12 cells is partially protected by N-acetylcysteine (NAC) (10 mM) and dithiothreitol (DTT) (500 mu M) pretreatment, confirming a role for oxidative processes. In addition, the treatment of FL5.12 cells with NDGA led to an increase in phosphorylation and activation of the MAP kinases ERK, JNK and p38. Although pretreatment with ERK inhibitors (PD98059 or U0126) abolished ERK phosphorylation in response to NDGA, neither inhibitor had any effect on NDGA-induced apoptosis. SP600125, a JNK inhibitor, did not have any effect on NDGA-induced phosphorylation of JNK nor apoptosis. Pretreatment with the p38 inhibitor SB202190 attenuated NDGA-induced apoptosis by 30% and also abolished p38 phosphorylation, compared to NDGA treatment alone. NAC, but not DTT, also decreased the phosphorylation of p38 and JNK supporting a role for oxidative processes in activating these kinases. Neither NAC nor DTT blocked the phosphorylation of ERK suggesting that this activation is not related to oxidative stress. The release of cytochrome c and activation of caspase-3 induced by NDGA were inhibited by NAC. SB202190 slightly attenuated caspase-3 activation and had no effect on the release of cytochrome c. These data suggest that several independent mechanisms, including oxidative reactions, activation of p38 kinase and cytochrome e release contribute to NDGA-induced apoptosis. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 38 条
[1]
Nordihydroguairetic acid, a lignin, prevents oxidative stress and the development of diabetic nephropathy in rats [J].
Anjaneyulu, M ;
Chopra, K .
PHARMACOLOGY, 2004, 72 (01) :42-50
[2]
Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells [J].
Arany, I ;
Megyesi, JK ;
Kaneto, H ;
Price, PM ;
Safirstein, RL .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 287 (03) :F543-F549
[3]
Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[4]
The specificities of protein kinase inhibitors: an update [J].
Bain, J ;
McLauchlan, H ;
Elliott, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2003, 371 :199-204
[5]
Glutathione oxidation and mitochondrial depolarization as mechanisms of nordihydroguaiaretic acid-induced apoptosis in lipoxygenase-deficient FL5.12 cells [J].
Biswal, SS ;
Datta, K ;
Shaw, SD ;
Feng, X ;
Robertson, JD ;
Kehrer, JP .
TOXICOLOGICAL SCIENCES, 2000, 53 (01) :77-83
[6]
Recruitment, activation and retention of caspases-9 and-3 by Apaf-1 apoptosome and associated XIAP complexes [J].
Bratton, SB ;
Walker, G ;
Srinivasula, SM ;
Sun, XM ;
Butterworth, M ;
Alnemri, ES ;
Cohen, GM .
EMBO JOURNAL, 2001, 20 (05) :998-1009
[7]
A relationship between 5-lipoxygenase-activating protein and bcl-xL expression in murine pro-B lymphocytic FL5.12 cells [J].
Datta, K ;
Biswal, SS ;
Xu, J ;
Towndrow, KM ;
Feng, X ;
Kehrer, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) :28163-28169
[8]
Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[9]
An introduction to the molecular mechanisms of apoptosis [J].
Delhalle, S ;
Duvoix, A ;
Schnekenburger, M ;
Morceau, F ;
Dicato, M ;
Diederich, M .
APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS, 2003, 1010 :1-8
[10]
Eisenmann KM, 2003, CANCER RES, V63, P8330